Christopher Gromisch
Pre-Doctoral Trainee
Boston University School of Medicine, Graduate Medical Sciences
Dept of Biochemistry






Development of a novel Antibody Drug Conjugate for the treatment of pancreatic cancer
09/01/2018 - 08/31/2021 (PI)
NIH/National Cancer Institute
5F30CA220843-03



Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Herrera VLM, Walkey AJ, Nguyen MQ, Gromisch CM, Mosaddhegi JZ, Gromisch MS, Jundi B, Lukassen S, Carstensen S, Denis R, Belkina AC, Baron RM, Pinilla-Vera M, Muller M, Kimberly WT, Goldstein JN, Lehmann I, Shih AR, Eils R, Levy BD, Ruiz-Opazo N. Increased Neutrophil-Subset Associated With Severity/Mortality In ARDS And COVID19-ARDS Expresses The Dual Endothelin-1/VEGFsignal-Peptide Receptor (DEspR): An Actionable Therapeutic Target. Res Sq. 2021 Sep 13.View Related Profiles. PMID: 34545358; PMCID: PMC8452107; DOI: 10.21203/rs.3.rs-846250/v1;
     
  2. Gromisch CM, Machado MA, Satyam V, Nunes D. Autoimmune Gastrointestinal Dysmotility in a Patient With HIV Treated With Methylprednisolone and Pyridostigmine. ACG Case Rep J. 2021 Jul; 8(7):e00636.View Related Profiles. PMID: 34307714; PMCID: PMC8294874; DOI: 10.14309/crj.0000000000000636;
     
  3. Gromisch CM, Tan GLA, Pasion KA, Moran AM, Gromisch MS, Grinstaff MW, Carr FJ, Herrera VLM, Ruiz-Opazo N. Humanized anti-DEspR IgG4S228P antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis ratnu/nu model. BMC Cancer. 2021 Apr 14; 21(1):407.View Related Profiles. PMID: 33853558; PMCID: PMC8048286; DOI: 10.1186/s12885-021-08107-w;
     
  4. Gromisch C, Qadan M, Machado MA, Liu K, Colson Y, Grinstaff MW. Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease. Cancer Res. 2020 08 15; 80(16):3179-3192.View Related Profiles. PMID: 32220831; PMCID: PMC7755309; DOI: 10.1158/0008-5472.CAN-19-2731;
     
  5. Wong CK, Gromisch C, Ozturk S, Papageorgis P, Abdolmaleky HM, Reinhard BM, Thiagalingam A, Thiagalingam S. MicroRNA-4417 is a tumor suppressor and prognostic biomarker for triple-negative breast cancer. Cancer Biol Ther. 2019; 20(8):1113-1120.View Related Profiles. PMID: 30922194; PMCID: PMC6605987; DOI: 10.1080/15384047.2019.1595285;
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 5 publications over 3 distinct years, with a maximum of 3 publications in 2021

YearPublications
20191
20201
20213

Contact for Mentoring:

700 Albany St Ctr for Adv Biomed Res
Boston MA 02118
Google Map


Gromisch's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department